U.S. Patent Office Reissues Patent for Diagnosis of Chronic Congestive Heart Failure

Nanogen, Inc., developer of advanced diagnostic products, announced that it has been granted U.S. Patent No. RE39,816, which is a reissue of United States Patent No. 6,461,828, titled “Conjunctive Analysis of Biological Marker Expression For Predicting Cardiac Mortality.”
Yahoo! Finance